CARBION OY has a total of 18 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Finland, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are WHITE MOUNTAIN PHARMA INC, GLYCOMIMETICS INC and CLAVIS PHARMA ASA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Finland | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Environmental technology | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Analysing materials | |
#5 | Fermentation | |
#6 | Polysaccharides | |
#7 | Climate change adaptation technologies | |
#8 | Enzymes | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Karlsson Karl-Anders | 10 |
#2 | Natunen Jari | 10 |
#3 | Miller-Podraza Halina | 9 |
#4 | Teneberg Susann | 7 |
#5 | Aangstroem Jonas | 6 |
#6 | Saarinen Juhani | 6 |
#7 | Satomaa Tero | 4 |
#8 | Helin Jari | 4 |
#9 | Milh Maan Abul | 1 |
#10 | Aitio Olli | 1 |
Publication | Filing date | Title |
---|---|---|
FI20021530A0 | Therapeutic carbohydrates for use in the treatment of allergies | |
FI20021275A0 | Therapeutic compositions for use in the prevention or treatment of diarrhea | |
FI20011671A0 | Tumor-specific oligosaccharide sequences and their use | |
FI20011664A0 | Cancer-specific oligosaccharide sequences and their use | |
FI20011402A | Drugs and treatments for pathogens | |
FI20011403A | Procedures and compositions for the treatment of gastric diseases | |
FI20010118A0 | New receptors for helicobacter pylori and their use | |
FI20001477A0 | Influenza virus binding agent and its use |